[HTML][HTML] Upgrading Treatment and Molecular Diagnosis in Endometrial Cancer—Driving New Tools for Endometrial Preservation?
One emerging problem for onco-gynecologists is the incidence of premenopausal patients
under 40 years of age diagnosed with stage I Endometrial Cancer (EC) who want to …
under 40 years of age diagnosed with stage I Endometrial Cancer (EC) who want to …
[HTML][HTML] Reproductive and Oncologic Outcomes in Young Women with Stage IA and Grade 2 Endometrial Carcinoma Undergoing Fertility-Sparing Treatment: A …
A Etrusco, AS Laganà, V Chiantera, M Mikuš… - Biomolecules, 2024 - mdpi.com
Background: Endometrial cancer (EC) is the most common gynecological malignancy in
both Europe and the USA. Approximately 3–5% of cases occur in women of reproductive …
both Europe and the USA. Approximately 3–5% of cases occur in women of reproductive …
Molecular subtyping in endometrial cancer: A promising strategy to guide fertility preservation
C Dagher, B Manning-Geist, LH Ellenson, B Weigelt… - Gynecologic …, 2023 - Elsevier
Objectives To investigate the association of molecular subtype with progesterone response
in patients with endometrial cancer (EC) or atypical endometrial hyperplasia (AEH). Methods …
in patients with endometrial cancer (EC) or atypical endometrial hyperplasia (AEH). Methods …